Virginie Borges-Cardoso

Virginie Borges-Cardoso

Auto-generated profile, based on publicly available information

Virginie Borges-Cardoso

Unité de Biologie des Infections Virales Emergentes, Institut Pasteur, Lyon, France

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 June 2021 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
MMMathieu MATEO
Mathieu MATEO
SRStephanie Reynard
Stephanie Reynard
AJAlexandra Journeaux
Alexandra Journeaux
CGClara Germain
Clara Germain
JHJimmy Hortion
Jimmy Hortion
SBSylvain Baize
Sylvain Baize
A single-dose vaccine confers cross-protection and long-term efficacy against Lassa virus in cynomolgus monkeys.

14 December 2023 in Blood
Verified
Journal Article
Closed access
PDF file
BLBlaise Lafoux
Blaise Lafoux
NBNicolas Baillet
Nicolas Baillet
CPCaroline Picard
Caroline Picard
GFGustave Fourcaud
Gustave Fourcaud
VBVirginie Borges-Cardoso
Virginie Borges-Cardoso
SBSylvain Baize
Sylvain Baize
Viral hemorrhagic fevers (HF) are a group of acute febrile diseases with high mortality rates. Although hemostatic dysfunction appears to be a major determinant of the severity of the disease, it is still unclear what pathogenic mechanisms lead to it. In clinical studies it is found that arenaviruses, such as Lassa, Machupo, and Guanarito viruses cause HF that vary in symptoms and biological alterations. In this study we aimed to characterize the hemostatic dysfunction induced by arenaviral HF to determine its implication in the severity of the disease and to elucidate the origin of this syndrome. We found that lethal infection with Machupo, Guanarito, and Lassa viruses is associated with cutaneomucosal, cerebral, digestive, and pulmonary hemorrhages. The affected animals developed a severe alteration of the coagulation system, which was concomitant with acute hepatitis, minor deficit of hepatic factor synthesis, presence of a plasmatic inhibitor of coagulation, and dysfunction of the fibrinolytic system. Despite signs of increased vascular permeability, endothelial cell infection was not a determinant factor of the hemorrhagic syndrome. There were also alterations of the primary hemostasis during lethal infection, with moderate to severe thrombocytopenia and platelet dysfunction. Finally, we show that lethal infection is accompanied by a reduced hematopoietic potential of the bone marrow. This study provides an unprecedented characterization of the hemostasis defects induced by several highly pathogenic arenaviruses.